|
[1] 中华医学会感染病学分会肝衰竭与人工肝学组.肝衰竭诊疗指南[J].中华传染病杂志, 2006, 24 (6) ∶422-425.
|
|
[2]Sakaida I, Terai S, Nishina H, et al.Development of cell therapy using autologous bone marrow cells for liver cirrhosis[J].Med Mol Morphol, 2005, 38 (4) ∶197-202.
|
|
[3]Zhan YT, Wei L, Chen HS, et al.Differentiation of bone marrow stem cells in rat hepatic fibrogenesis environment[J].ZhonghuaGanzangbing Zazhi, 2003, 11 (11) ∶673-675.
|
|
[4]Fang B, Shi M, Liao L, et al.Systemic infusion of FLK1 (+) mesenchymal stem cells ameliorate carbon tetrachloride-induced liverfibrosis in mice[J].Transplantation, 2004, 78 (1) ∶83-88.
|
|
[5]Yannaki E, Athanasiou E, Xagorari A, et al.G-CSF-primedhematopoietic stem cells or G-CSF per se accelerate recovery andimprove survival after liver injury, predominantly by promotingendogenous repair programs[J].Exp Hematol, 2005, 33 (1) ∶108-119.
|
|
[6] 高志良, 彭亮, 崇雨田, 等.骨髓间充质干细胞自体移植治疗慢性肝衰竭的疗效研究[J].现代消化及介入诊疗, 2007, 12 (S) ∶2327.
|
|
[7]姚鹏, 王帅, 胡大荣, 等.肝动脉自体骨髓干细胞移植治疗失代偿期肝硬化30例[J].世界华人消化杂志, 2005, 13 (13) ∶1639-1640.
|
|
[8]夏凌辉, 方峻, 游泳, 等.造血干细胞移植后肝静脉闭塞病的临床观察[J].临床内科杂志, 2007, 24 (2) ∶98-100.
|
|
[9]Lorenzini S, Andreone P.Stem cell therapy for human liver cirrhosis:A cautious analysis of the results[J].Stem Cells, 2007, 25 (9) ∶2383-2384.
|